Pages that link to "Q30765398"
Jump to navigation
Jump to search
The following pages link to Molecular classification of breast carcinomas using tissue microarrays (Q30765398):
Displayed 50 items.
- BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (Q24610409) (← links)
- Tissue microarrays (Q30828400) (← links)
- Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data (Q31122536) (← links)
- A systems approach to clinical oncology: focus on breast cancer (Q33238889) (← links)
- Proteomics of breast cancer: principles and potential clinical applications (Q33245053) (← links)
- Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer (Q33251551) (← links)
- A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study (Q33276929) (← links)
- Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer (Q33338630) (← links)
- Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies (Q33593016) (← links)
- Clinical proteomics of breast cancer (Q33885885) (← links)
- Nuclear CSPP1 expression defined subtypes of basal-like breast cancer (Q33918128) (← links)
- St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial (Q34463987) (← links)
- Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays (Q34466187) (← links)
- Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer (Q35074445) (← links)
- Genome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer (Q35097632) (← links)
- The pathology of hereditary breast cancer (Q35355084) (← links)
- Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy (Q35591546) (← links)
- Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer (Q36001510) (← links)
- p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading. (Q36107330) (← links)
- The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications (Q36149597) (← links)
- A Comparison of Clinical Features, Pathology and Outcomes in Various Subtypes of Breast Cancer in Indian Women (Q36163073) (← links)
- Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer (Q36180689) (← links)
- Tissue microarrays: bridging the gap between research and the clinic (Q36184792) (← links)
- Immunoprofile from tissue microarrays to stratify familial breast cancer patients (Q36413928) (← links)
- A new genome-driven integrated classification of breast cancer and its implications (Q36664694) (← links)
- Astronomical algorithms for automated analysis of tissue protein expression in breast cancer (Q36671817) (← links)
- Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series (Q36873822) (← links)
- Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer. (Q36908377) (← links)
- Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics (Q36973076) (← links)
- Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery (Q37137019) (← links)
- African American Race is an Independent Risk Factor in Survival from Initially Diagnosed Localized Breast Cancer (Q37290523) (← links)
- Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer. (Q37330694) (← links)
- Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival (Q37401549) (← links)
- Triple negative breast cancers: clinical and prognostic implications. (Q37602289) (← links)
- Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer. (Q37681710) (← links)
- Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis (Q38418118) (← links)
- PathGrid: a service-orientated architecture for microscopy image analysis (Q38428392) (← links)
- MDM2 protein expression is a negative prognostic marker in breast carcinoma. (Q38440364) (← links)
- Regulation of iron homeostasis by the p53-ISCU pathway (Q38820048) (← links)
- Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters (Q39974519) (← links)
- Identification and validation of an ERBB2 gene expression signature in breast cancers (Q40595739) (← links)
- Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial (Q42435532) (← links)
- An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer (Q42473072) (← links)
- p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas (Q42481125) (← links)
- A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences (Q42497579) (← links)
- Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer (Q42505879) (← links)
- Basal markers and prognosis in luminal breast cancer (Q42506475) (← links)
- Differential pathological response to preoperative chemotherapy across breast cancer intrinsic subtypes (Q42517316) (← links)
- Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis (Q42518714) (← links)
- Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas). (Q42519161) (← links)